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Introduction: Colorectal cancer (CRC) shows high incidence and mortality worldwide, partic-
ularly in Western and developed countries. The objective of this study is to evaluate the
oncologic results during a minimum follow-up of 2 years of curable CRC patients submit-
ted  to laparoscopic resection in our environment, regarding to the development of hepatic
metastases.
Methods: Medical records of 189 colon and rectal patients with potentially curable adenocar-
cinoma who have been submitted to laparoscopic resection have been reviewed through a
retrospective cohort between January 2005 and March 2012 at a single institution regarded
as  reference to this type of treatment. Pearson’s 2 and Long-rank tests have been used for
statistical analysis and data was analyzed by statistic package STATA version 11.0.
Results: The eligible population for the study was 146 patients, 91 women (62%), with a
mean age of 61 ± 13 years. Minimum follow-up was 24 months, having an mean follow-up
of  60 ± 27 months and an mean follow-up of global disease recurrence of 27 ± 11 months.
Hepatic metastases occurred in 7.5% of the population, most from stage III, and the mean
recurrence period was 25 ± 16 months.
Conclusions: Laparoscopic resection for potentially curable CRC in this cohort did not change
the long-term incidence of hepatic metastases, considering that our results are comparable
to  large randomized clinical trial results. Laparoscopic resection was effective and safe for
analyzed patients, regarding long-term oncologic results.©  2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. All
rights reserved.∗ Corresponding author.
E-mail: rerostirolla@terra.com.br (R. Rostirolla).
http://dx.doi.org/10.1016/j.jcol.2015.12.002
2237-9363/© 2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. All rights reserved.
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Impacto  da  cirurgia  videolaparoscópica  em  ressecc¸ões  de  câncer  colorretal
quanto  ao  desenvolvimento  de  metástases  hepáticas  a  longo  prazo
Palavras-chave:
Câncer colorretal
Cirurgia laparoscópica
Colectomia vídeo-assistida
Resultados a longo prazo
Metástases hepáticas
r  e  s  u  m  o
Introduc¸ão: O câncer colorretal (CCR) apresenta elevada incidência e mortalidade mundial,
especialmente nos países ocidentais e desenvolvidos. O objetivo deste estudo é avaliar,
durante um seguimento mínimo de 2 anos, pacientes com CCR potencialmente curável
submetidos a ressecc¸ões laparoscópicas, em relac¸ão ao surgimento de metástases hepáti-
cas.
Métodos: Através de coorte retrospectiva foram revisados os prontuários de 189 porta-
dores de adenocarcinoma de cólon e reto potencialmente curáveis, submetidos a ressecc¸ão
laparoscópica entre janeiro de 2005 e marc¸o de 2012, numa única instituic¸ão considerada
de  referência neste tipo de tratamento. Para análise estatística foram usados o teste 2 de
Pearson e o teste Log-rank, e os dados foram analisados pelo pacote estatístico STATA versão
11.0.
Resultados: A populac¸ão elegível do estudo foi de 146 pacientes, sendo 91 mulheres (62%),
com  idade média de 61 ± 13 anos. O seguimento mínimo foi de 24 meses, sendo o tempo
médio de seguimento de 60 ± 27 meses, e o tempo médio de recorrência global da doenc¸a
de  27 ± 11 meses. Metástases hepáticas ocorreram em 7,5% da populac¸ão, a maioria prove-
niente do estadio III, e o tempo médio de recorrência no fígado foi de 25 ± 16 meses.
Conclusões: Para esta coorte a ressecc¸ão do CCR potencialmente curável por via laparoscópica
não  modiﬁcou a incidência de metástases hepáticas a longo prazo, ao comparar nossos
resultados aos dos grandes ensaios clínicos randomizados. Para os pacientes analisados, a
ressecc¸ão  laparoscópica foi eﬁcaz e segura em relac¸ão aos resultados oncológicos a longo
prazo.
©  2016 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda.
Todos os direitos reservados.
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orldwide, colorectal cancer (CRC) is the third most com-
on  malignancy and the fourth most responsible for mortality
elated to cancer.1 Its incidence is higher in industrialized and
estern countries, such as those in Western Europe, USA and
ustralia, and is growing in Asian countries such as Japan
nd Hong Kong, where historically the risk of the disease was
ow.2–6 Its incidence is also high in Brazil; and for the year
014, the National Cancer Institute (INCA) estimated 32,600
ew cases.7
Despite the medical technology and pharmaceutical indus-
ry advancements observed, surgical resection remains the
ain therapeutic modality for CRC, being the only considered
urative.8–11
After initial reports of colorectal resections by laparoscopy,
rom the ﬁrst publication in 1991 by Jacobs et al. 12 the tech-
ique has become widespread. Concerns about the quality of
esection, including the status of surgical margins and the
adicalism of the lymphadenectomy, and also about the long-
erm oncological results, prompted a series of studies and
andomized prospective clinical trials, the most important
eing the Barcelona, COST, CLASICC and COLOR studies.13–23he results of these trials showed that, in experienced hands,
aparoscopy has a beneﬁcial effect on post-operative recovery,
hen compared to open surgery, without compromising the
ncological results in the long run.Because of numerous publications speaking in favor of the
technique and the increasing ability of surgeons, there was
a signiﬁcant increase in the number of colorectal surgeries
by laparoscopy in the last decade around the world, and also
among us. As the approach had a strong penetration in the
treatment of malignant disease, we believe that it is neces-
sary to ensure that the good results obtained in randomized
clinical trials are similarly occurring also outside of these
contexts.
Whereas the most frequent site of colorectal metastasis is
the liver,24 and liver metastases are the main cause of mortal-
ity in these patients,25 this study aims to verify the emergence
of liver metastasis in potentially curable CRC patients oper-
ated by laparoscopy in a reference center in our midst during
a minimum follow-up of 2 years.
Patients  and  methods
Patients
This study follows a retrospective observational model, hav-
ing been submitted and approved by the Ethical Committee of
the Hospital e Maternidade Municipal Nossa Senhora Monte
Serrat.
The study included patients with colon and rectum
adenocarcinoma in stages I, II and III by TNM classiﬁca-
tion, according to the American Joint Committee on Cancer
o j). 210  j coloproctol (ri
(AJCC) and the International Union Against Cancer (IUAC),26
and which underwent laparoscopic surgical resection with
curative intent between January 2005 and March 2012 by
the same surgical team at a referral center for advanced
laparoscopic colorectal surgery: Instituto Lubeck, Itu – São
Paulo.
Patients operated in emergency due to intestinal obstruc-
tion or perforation, patients with synchronous liver metas-
tases or other distant metastases (stage IV by AJCC and
IUAC),26 patients undergoing surgery without curative intent,
those carriers of concomitant inﬂammatory bowel disease,
patients in Stage 0 (carcinoma in situ), and patients whose
loss of follow-up occurred before reaching two years postop-
eratively were excluded.
Preoperative  evaluation
The standard pre-operative evaluation included laboratory
tests, including carcinoembryonic antigen (CEA), radiography
or chest tomography, computed tomography (CT) abdominal
and pelvic (in cases of rectal tumor) and colonoscopy.
Surgical  technique
Laparoscopic surgery followed current oncological patterns:
high lymphovascular ligation, longitudinal and circumfer-
ential safety margins, comprehensive lymph node resection,
bowel mobilization and identiﬁcation of anatomical struc-
tures without tumor manipulation, protection of the site used
for specimen extraction, and exploration of the abdominal
and pelvic cavity. The dissection of the colon was performed
on a medial-lateral direction, with total resection of the corre-
sponding mesocolon. The resection of the rectum was held in
conjunction with a total mesorectal excision, or from mesorec-
tum to the level of rectal section. The anastomoses in the right,
transverse and descending colon were extracorporeal proce-
dures, through the incision used for specimen extraction, and
made by manual or mechanical technique. Colorectal anas-
tomoses in surgery for sigmoid colon and rectum consisted
in intracorporeal and mechanical procedures (double
stapling).
Complementary  therapy
Patients with rectal adenocarcinoma in clinical stage T3, T4 or
with positive lymph nodes underwent preoperative radiation
therapy and chemotherapy, and were treated with surgical
resection between 6 and 8 weeks after completion of neoad-
juvant therapy.
Adjuvant chemotherapy was administered to patients with
cancer of the colon or rectum in stage III, and to patients
in stage II with poorer prognosis criteria, such as vascu-
lar, lymphatic and perineural tumor invasion, tumors poorly
differentiated, and intestinal wall impairment of T4 grade.
Patients aged over 75 years and those who rejected the treat-
ment were not submitted to adjuvant therapy.Therapeutic radiotherapy and chemotherapy were per-
formed as recommended by the National Comprehensive
Cancer Network (NCCN).27 0 1 6;3 6(1):8–15
Data  collection
From chart review, the following data was recorded: date of
surgery and age at the time of the procedure, tumor loca-
tion and type of colorectal laparoscopic resection, pathological
tests, including degree of tumor differentiation, number of
lymph nodes resected and their involvement, degree of intesti-
nal wall invasion, and tumor stage according to the TNM
staging system proposed by AJCC and IUAC, status of proxi-
mal, distal and circumferential surgical margins of the surgical
specimen, and postoperative mortality considered until the
30th day of surgery.
The follow-up data collected were CEA, abdominal and
pelvic CT (in cases of rectal tumor), chest radiography or CT
and colonoscopy. Patients without a complete colonoscopy
before the treatment were examined after surgery or after
adjuvant therapy. The remaining patients repeated the
colonoscopy after one year of treatment; and all, from a com-
plete examination, underwent endoscopic surveillance every
3–5 years.
Follow-up
The follow-up was considered from the date of surgery to the
appearance of liver metastasis, or development of a distant
metastasis in another site, locoregional recurrence, until the
date of death for reasons not related to the primary tumor, or
until the last medical visit.
Statistical  analysis
The statistical analysis consisted in verifying the distribution
and re-coding of the variables. For the descriptive analysis,
the variables were expressed as mean, standard deviation,
frequency distribution, conﬁdence intervals at 95%, and per-
centage. We conducted comparisons of proportions among
variables using Pearson’s 2 test.
The association among exposure variables and the appear-
ance of metastasis was evaluated by Kaplan–Meier analysis,
using the log-rank test. For this purpose, behavior of the
variable “response at the end of the exposure in time” was
interpreted in the following presentation: (i) characterization,
for each patient, of the failure situation (recurrence of can-
cer), interpreted by the elapsed time between the entry of
the patient in the study until the occurrence of the event of
interest; (ii) deﬁnition, for each patient, of the situation of
censorship, interpreted when the event of interest had not
occurred until the end of observation, or until the patient loss
during follow-up.
P values <0.05 were considered statistically signiﬁcant, and
the data were analyzed using the statistical package STATA
version 11.0 (Stata Corp, College Station, TX, USA).
ResultsMedical records of 189 patients undergoing laparoscopic
resection of colon or rectal cancer without signs of widespread
disease (stages I–III), with a minimum of 2 years follow-up,
operated with curative intent between January 2005 and March
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Table 1 – Clinical characteristics of patients.
Characteristics
Female, n (%) 91 (62)
Age in years, mean ± SD 61 ± 13
Tumor location, n (%)
Caecum 5 (4)
Ascending colona 21 (14)
Transverse colonb 4 (3)
Descending colon 7 (5)
Sigmoid colon 56  (38)
Rectum 53 (36)
Intervention, n (%)
Right colectomy 25 (17)
Transverse resection 4 (3)
Left colectomy 7 (5)
Rectosigmoidectomy 105 (71)
Abdominoperineal resection of the rectumc 4 (3)
Total colectomy 1 (1)
Lymph nodes resected, mean ± SD 24 ± 12
Extension of the primary tumor, n (%) 14 (10)
T1 42 (28)
T2 77 (53)
T3 13 (9)
T4
Lymph node metastasis, n (%) 106 (72)
N0 26 (18)
N1 14 (10)
N2
Stage tumor, n (%) 53 (36)
I 53 (36)
II 40 (28)
III
Histology, n (%) 15 (10)
Well differentiated 120 (82)
Moderately differentiated 11 (8)
Sample size = 146 patients; n, number of patients; % Percentage; SD,
standard deviation.
a Includes the hepatic angle.
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Table 2 – Tumor recurrence and mortality.
Overall tumor recurrence, n (%) 19 (13.5)
Recurrence type, n (%)
Liver metastasis 11 (7.5)
Pulmonary metastasis 4 (3)
Regional locus 3 (2)
Carcinomatosis 1 (1)
Recurrence time in months,
mean ± SD
27  ± 11
Follow-up time in months,
mean ± SD Perioperative
mortality, n (%)
60  ± 27
Overall tumor recurrence, n (%) 1 (1)Includes splenic angle.
c Rectum amputation.
012, were reviewed. As the exclusion criteria, 43 patients were
xcluded from this sample.
The population eligible for analysis in this study was
omposed of 146 patients; 91 were female (62%) and the
ean age was 61 ± 13 years. The most frequent tumor
ite was sigmoid colon (56/38%), and the more  often per-
ormed intervention was a retosigmoidectomy (105/71%).
he mean number of resected lymph nodes was 24 ± 12,
nd 3 cases had compromised their circumferential surgi-
al margin (<2 mm disease-free margin); these were cases
f rectal cancer with inﬁltration of the intestinal wall (T4).
 patient with impaired surgical margin showed locore-
ional recurrence 24 months after resection of the primary
umor. There were no cases of compromised longitudinal
argins. Tumor stages more  incident in this population
ere I and II, with 53 cases each. Most tumors exhib-ted a moderate degree of tumor differentiation (120/82%).
he characteristics of the study population are shown in
able 1.Sample size = 146 patients; n, number of patients; %, percentage; SD,
standard deviation.
As the minimum follow-up given in the study was two
years, patients operated until March 2012 were included.
The overall tumor recurrence occurred in 19 patients, rep-
resenting an incidence of 13% of the study population. Liver,
lung, locoregional sites and peritoneum (carcinomatosis) were
the sites of recurrence, as shown in Table 2. There was no
recurrence at the site of trocars. The most frequent location of
metastases was in the liver, occurring in 11 patients (7.5%). The
mean time of overall disease recurrence was 27 ± 11 months,
with a mean follow-up of the study population of 60 ± 27
months. The operative mortality was only one female patient
with stage II, victimized by a pulmonary thromboembolism on
the 12th postoperative day. Table 2 shows the types of recur-
rence and the follow-up time until the event.
Patients with stage III had a higher number of recurrences
(10/7%) (P 0.030), and a lower mean time until its occurrence
(21 months), compared to the other stages (CI 95%: 16–26) (P
0.05), a statistically signiﬁcant difference, as shown in Table 3.
Of the 11 patients who developed liver metastases, the
majority came from the stage III, and seven patients had
primary colon tumor. Three patients with liver metastasis
simultaneously presented lung metastases, and two of these
patients exhibited primary neoplasm of the rectum, and one of
the colon. The mean time to recurrence in the liver was 25 ± 16
months. Table 4 shows the proﬁle of patients who  developed
liver metastases.
Discussion
Colorectal cancer is a public health problem worldwide,
because in addition of its high incidence, this disease is asso-
ciated with high mortality. The prognosis is good if the disease
is diagnosed at an early stage,1,2,28 but about 25% of patients
already have liver metastases at diagnosis.24,29 The policy
of prevention with screening tests for premalignant lesions
and diagnosis of the disease at an early and asymptomatic
stage is still deﬁcient in our country. Thus, we  are faced with
large numbers of patients eligible for surgery. The use of
laparoscopy in the treatment of malignant disease of the large
intestine and rectum is growing throughout the world and
also in our midst. Recently, large-scale randomized studies
have demonstrated the non-inferiority of laparoscopic surgery
over open surgery for the treatment of CRC regarding the
12  j coloproctol (rio j). 2 0 1 6;3 6(1):8–15
Table 3 – Recurrence of disease by stage.
Recurrence I II III Total
Numbera, n (%) 3 (2) 6 (4) 10 (7) 19 (13)
Time in monthsb, Mean (CI 95%) 40 (9–71) 31 (24–38) 21 (16–26) 27 (21–33)
Sample size = 146 patients; n, number of patients; %, percentage; CI 95%, conﬁdence interval of 95%.
a Pearson’s 2 test, P 0.030.
b Log-rank test, P 0.05.
Table 4 – Recurrence by liver metastasis.
Gender Localization Primary tumor Stage Disease-free time
(months)
2nd  place of recurrence
1 F Rectum T2, N0 I 12 Pulmonary
2 M Sigmoid T3, N0 II 24 –
3 F Sigmoid T3, N0 II 6 –
4 M Sigmoid T3, N0 II 28 –
5 F Rectum T3, N0 II 42 Pulmonary
6 F Sigmoid T3, N1 III  36 –
7 M Sigmoid T2, N1 III 60 Pulmonary
8 F Ascending T3, N1 III 24 –
9 M Rectum T3, N2 III 10 –
10 M Sigmoid T3, N1 III 11 –
11 F Rectum T3, N1 
oncological results in the long run.30 The aim of this study
was to determine whether the good results of laparoscopic
colorectal surgery that abound in the current international
literature,14–23 are in fact occurring in our country, that is,
outside the favorable context of randomized controlled trials.
Despite the difﬁculty of performing a retrospective cohort
due the incomplete data storage and loss to follow up of
patients, 146 patients with colon and rectal adenocarcinomas
in stages I–III submitted to surgical laparoscopy with curative
intent and with a minimum follow-up of 2 years were enrolled
in this study. Patients treated at the institution here consid-
ered are submitted to surgery through laparoscopy, almost
without exception, irrespective of exhibiting physical and/or
tumor characteristics favorable to the technique. Due to the
high degree of surgical team expertise, conversions to laparo-
tomy occur only rarely, although compliance with these rates
extrapolates the nature of this study. Patients with tumors
at all stages, except those metastatic ones, including those
with locally advanced, bulky tumors, were included. Like-
wise, patients with transverse colon, splenic angle and rectum
malignancies, which are considered technically more  labor-
intensive and difﬁcult to resect laparoscopically, participated
in this study, making our sample broader, compared to that of
recently published clinical trials that excluded patients with
tumors in these locations.14,18,20,22,31
In the population studied, 62% of tumors had inﬁltration
into the intestinal wall (T3 and T4), making up a group of
patients with locally advanced tumors; and almost one third
of patients (28%) was in stage III. Despite the greater tech-
nical difﬁculty to resect rectal tumors, taking into account
that the pelvic cavity is narrow and surrounded by rigid bony
structures that make it difﬁcult the laparoscopic instrumen-
tation, 36% of our population was operated for colorectal
neoplasia.III 22 –
Sixty-two percent of patients were female, differing from
the world literature, which points to males having a higher
incidence in most populations,1,2,4 but according to Brazil-
ian data, that show a higher relative risk for women  in our
country.1 Regarding age, the study population had a mean age
of 61 years, and this age proﬁle matches up to current data,
showing that 90% of CRC patients were over 50 years old at
diagnosis.4,6
The study was designed for a minimum follow-up of 24
months, according to data of the American Society of Clini-
cal Oncology (ASCO) and other studies that demonstrate the
occurrence of 75–80% of relapses occurring within the ﬁrst two
years after resection of the primary tumor.32,33 Considering
that the mean follow-up was 60 ± 27 months for this cohort,
it is likely that our records have included the majority of the
recurrences, making this a relevant study for the veriﬁcation
of long-term oncological results.
The literature points to two major criteria related to qual-
ity of tumor resection: the status of surgical margins and the
quality of lymphadenectomy.2,33
Regarding the surgical margins we found a rate of 5.66%
of circumferential margins committed, considering only cases
of rectal surgery, since this commitment was observed in 3
of 53 patients operated for rectal adenocarcinoma, and in
no case of colonic tumor. The ﬁrst large randomized clinical
trial including patients with rectal cancer was the CLASICC
study, which showed positive circumferential margins in 12%
for the group laparoscopically operated versus 6% for the
group of open surgery.20 Also in comparison with COLOR II
study, published more  recently and with short-term results
of 1044 patients with rectal cancer randomized to treatment
by laparoscopy or open surgery, our rate of positive margins
was lower, since COLOR II found 10% of compromised cir-
cumferential margins in both groups.34 Just as in COLOR II
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tudy, we  considered as positivity for circumferential margin
ommitment the presence of tumor cells in those outermost
adial 2 mm of the surgical specimen. Although some authors
onsider the thickness of 1 mm free of neoplastic cells as sufﬁ-
ient, and Nagtegaal et al. concluded that the local recurrence
isk of rectal neoplasms changes from 5.8% to 16% when the
ircumferential surgical safety margin is greater or smaller
han 2 mm,  respectively.35
The number of lymph nodes removed during resection of
olorectal malignancy is used as a quality criterion of the
ncological resection.36 The AJCC considers that at least 12
ymph nodes should be in the surgical specimen for a proper
ncological staging.2 In this study, the mean number of lymph
odes resected was 24 ± 12 which, besides demonstrating the
dequacy of lymphadenectomy, exceeds the mean published
y several other authors like Lacy et al., Braga et al. and Liang
t al., among others.37,38
The overall recurrence rate of the disease was 13%, with
he addition of hepatic, lung, and locoregional recurrences
nd of peritoneal carcinomatosis. Historically, these sites
re the most affected when there is tumor dissemination.32
he data in the literature are quite variable, with rates
f relapse between 9% and almost 30%, usually observed
p to 5 years after resection of the primary tumor.16–23
mong the studies with a greater number of patients are
he Barcelona,19 Conventional versus Laparoscopic-Assisted
urgery in Colorectal Cancer (CLASICC),21 and the Colon
ancer Laparoscopic or Open Resection (COLOR),23 which pub-
ished overall recurrence rates of 16.98%, 23.57% and 19.66%,
espectively. Considering these and other large-scale trials, we
ound that the overall recurrence rate found in this study is
ower than the mean of contemporary studies.37,38 We believe
hat the favorable results obtained here may be due, at least
n part, to the high technical expertise and extensive experi-
nce in laparoscopic colorectal surgery of the surgical team,
onsidering the criteria that qualify the oncologic resections
forementioned.
Some authors such as Braga et al., Leung et al., Liang
t al., and Mirza et al. found incidences of distant metastases
etween 14% and 20% in the long term.37,38
Our goal was to identify, speciﬁcally, the incidence of liver
etastases, since these are mainly responsible for the mor-
ality associated with CRC.25 In our study, we  found liver
isease recurrence in 7.5% of patients operated laparoscop-
cally. Most patients with this relapse pattern were in stage III.
n a prospective non-randomized study coordinated by Felli-
iotti et al. which evaluated 197 patients undergoing right or
eft hemicolectomy for treatment of CRC, the group treated
ith laparoscopy had a liver recurrence rate of 8.1% from the
isease, compared to 10.7% in patients operated by laparo-
omy with a follow-up of three years.39 Still taking into account
he incidence of liver metastases published in the Clinical
utcomes of Surgical Therapy (COST) study14 which analyzed
72 patients operated for colorectal adenocarcinoma (except
ransverse colon), and that showed 5.8% of hepatic recurrence
fter 5 years in the group operated by laparotomy and 5.5%
n patients undergoing laparoscopy, our results are thus com-
arable. In a recently published Australian trial involving 601
atients with colon cancer (except transverse colon), the dis-
ase recurred in 13.7% of patients operated by laparoscopy, 1 6;3 6(1):8–15 13
with 60% of these recurrences were in the liver (8.22%), and
most of them occurring in the ﬁrst 2 years after surgery of the
primary tumor.31
Our analyzes included all cases of colon and rectum neo-
plasms, and it is worth mentioning the fact that more  than a
third of patients have been operated for colorectal cancer, a
location not included in most randomized clinical trials pub-
lished to date. In a Japanese study evaluating only rectal and
rectosigmoid transition tumors, the rate of liver metastases
was only 1.5% in a follow-up of 3 years. This ﬁnding proba-
bly was related to the fact that only T1 and T2 tumors were
included.40
In contrast, Laurenti et al., in a study which included only
rectal neoplasms, with most of the locally advanced type,
found disease-free survival at 5 years similar to laparoscopy
and laparotomy surgery groups, with distant metastasis rate
of 20, 6% and 24.9%, respectively.41 In a meta-analysis that
pooled 2095 patients with rectal cancer from 12 publications,
late oncological results similar between laparoscopy and open
surgery groups were found.42 COLOR II, an ongoing clini-
cal study, randomized 1044 patients with rectal cancer for
laparoscopic resection or open surgery; soon, this study will
bring more  deﬁnitive oncological results in the long run, with
respect to the use of laparoscopy for the treatment of rectal
cancer.34
In our study, we  found a relationship between the segmen-
tal location of the primary tumor and increased chance of liver
metastasis development.
The mean time to recurrence of the disease in the liver
was 27 ± 11 months, and this ﬁnding is consistent with the
literature, that shows the occurrence of most relapses until
the ﬁrst 2.5 years after treatment of the primary tumor.32,33
The operative mortality occurred in a woman with a stage
II tumor due to pulmonary thromboembolism on the 12th day
after the surgery, despite the routine administration of anti-
coagulants and early ambulation in the perioperative period.
Thus, the study population had 1% of operative mortality,
which is comparable to data from the meta-analysis involv-
ing studies of Barcelona, COST and CLASSIC, which found a
mortality of 1.6% for conventional colorectal surgery and 1.4%
for laparoscopic surgery.43
In light of current knowledge, it is observed that the
extent and quality of oncologic resection – speciﬁcally the
number of lymph nodes removed, colonic or rectal length
resected and corresponding mesos, as well as circumfer-
ential margins – do not differ between laparoscopy and
laparotomy.17,18,20,22 Also with respect to long-term results,
a current meta-analysis that compiled data from more  than
4500 patients from 12 randomized clinical trials showed no
difference as to overall recurrence, local or distant recurrence,
overall mortality or mortality associated with cancer, and
disease-free survival at 3 and 5 years between resections by
laparoscopy versus open surgery.37,38 What is still debatable
are the long-term oncological results of laparoscopic resec-
tions for CRC outside the context of randomized controlled
trials.14,19,21,34
The contribution of this study lies in having analyzed an
actual sample of the population, that is, without excluding
carriers of locally advanced tumors and/or tumors in more
difﬁcult locations for laparoscopic resection.
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Conclusion
We  conclude that, for the population of this study, the use
of laparoscopy in the resection of potentially curable CRC did
not alter the incidence of liver metastases in the long term,
compared to publications of international randomized clinical
trials. For the patients analyzed, laparoscopic resection was
considered as an effective and safe method in the treatment
of CRC, concerning oncological results in the long run.
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